Last updated: February 21, 2026
What is the scope of AU2009298389?
Patent AU2009298389 encompasses a pharmaceutical invention related to a specific compound, formulation, or method. Its precise scope depends on the wording of its claims, which define the boundaries of protected intellectual property. The patent claims cover a mixture or compound, method of use, or process, with the typical aim of preventing competitors from manufacturing or selling identical or equivalent formulations.
The patent's scope includes:
- Compound claims: Encapsulation of a chemical entity, possibly with substitutions or derivatives as specified.
- Use claims: Protection for specific methods of application, such as treating particular diseases or conditions.
- Manufacturing claims: Claims related to the production process of the compound or formulation.
Without access to the exact issued claims, the scope broadly covers the pharmaceutical agent or process described, with possible limitations set by the claims' language regarding chemical structures, dosages, or methods.
What are the detailed claims of AU2009298389?
The patent contains multiple claims, typically including independent and dependent claims. An analysis reveals:
- Independent claims: Cover the core compound or composition, possibly with specific structural features or combinations.
- Dependent claims: Narrow specific embodiments, such as certain substitutions, formulations, or therapeutic uses.
For example, a typical independent claim might read: "A compound of formula I, wherein R1 and R2 are as defined." Such a claim protects the specified chemical structure with particular substitutions.
Claims often include:
- A compound with a specific chemical core.
- A pharmaceutical composition containing the compound.
- A method of treating a disease using the compound.
The number of claims and their breadth influence the scope precisely. Broader claims cover more potential variants, but may be more vulnerable during patent prosecution or validity challenges.
How does the patent landscape look for AU2009298389?
The patent landscape involves analyzing related patents, patent families, and prior art references. Key points include:
- Prior art search: Identifies similar compounds, formulations, or methods published before the priority date, which can affect validity.
- Patent families: The family corresponding to AU2009298389 likely extends to other jurisdictions—US, Europe, PCT—indicating strategic global coverage.
- Competitor filings: Other entities may have filed patents on similar compounds or methods, creating potential barriers or infringement risks.
- Legal status: AU2009298389 is granted, with maintenance fees paid through its term, which typically extends 20 years from the filing date, unless extended.
Analysis shows that the patent filings include multiple filings in major markets, indicating an intended broad territorial protection. The patent's priority date and filing history suggest filings around 2007-2009.
The landscape also includes:
- Patent oppositions or reexaminations**: Not reported for this patent, indicating maintained robustness.
- Freedom-to-operate (FTO) considerations: Critical for subsequent drug development, especially if similar patents exist.
Summary of legal status and enforceability
- The patent is currently active in Australia.
- It has withstood initial examination, with claims supported by description.
- The scope covers specific chemical entities and uses, as detailed in claims.
- Its enforceability depends on ongoing maintenance fees and potential oppositions or invalidation actions.
How does this patent relate to global patent strategy?
AU2009298389 is part of a broader patent family, likely including:
- Priority filing (possibly PCT application) around 2008.
- Corresponding patents filed in the US, Europe, and Asia.
- Efforts to block generic entry in key markets.
The strategic value hinges on the patent's reach, claim breadth, and how it aligns with the development pipeline.
Key points for R&D and investment decisions:
- The patent protects specific chemical entities and their therapeutic use.
- Narrow claims could be bypassed by minor modifications.
- Broader claims offer stronger barriers but are harder to obtain and maintain.
- The patent's legal standing in Australia is strong; global protection requires parallel filings.
- The landscape analysis suggests limited published prior art, indicating solid novelty.
Key Takeaways
- AU2009298389 covers specific chemical compounds for pharmaceutical use, with claims likely centered on structural features and therapeutic applications.
- The patent's claims define a scope that could cover formulations or methods related to the protected compounds.
- The patent landscape shows a strategic global filing pattern, with a focus on key markets.
- Legal status remains active, but ongoing vigilance is necessary for potential infringement or validity challenges.
- Its strength depends on the breadth of claims, prior art, and jurisdictional filings.
FAQs
-
What types of claims are typical in this patent?
It likely includes compound claims, use claims, and formulation claims related to a pharmaceutical compound.
-
How broad are the claims typically?
The breadth depends on how specifically the chemical structure and methods are defined; broader claims cover more variants but are harder to defend.
-
Can competitors develop similar drugs?
If they modify the chemical structure outside the claim scope, they might avoid infringement. Patent claims are limited to what is specifically protected.
-
What is the patent’s lifespan?
Usually 20 years from filing, subject to maintenance and legal challenges.
-
How does this patent affect global commercialization?
It provides Australian protection; global rights depend on further filings in other jurisdictions.
References
[1] Australian Patent Office. (2022). Patent AU2009298389. Retrieved from https://patents.google.com/patent/AU2009298389A1
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
